Ibandronate Sodium Hydrate
Tier C — Watch / tradeIbandronate Sodium Hydrate
Targets：Bone resorption factor, FDPS
Brand：Bondronat, Bondenza, Bonviva (former Brand Name), Destara, Bonviva, Boniva/Bonviva, Boniva
Indications (approved)：Osteoporosis, Postmenopausal osteoporosis, Hypercalcaemia, Bone injury, Breast cancer, Metastatic cancer
Regional status
Synthetic routes & intermediates5 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| IBAN-001 | 110-58-7 | pentan-1-amine |
| IBAN-002 | 100-52-7Available | benzaldehyde |
| IBAN-003 | 22710-00-5 | 3-(methyl(pentyl)amino)propanoic acid hydrochloride |
| IBAN-004 | 25468-43-3 | (E)-N-benzylidenepentan-1-amine |
| IBAN-005 | 77223-58-6 | N-benzyl-N-methylpentan-1-amine |
| IBAN-006 | 25419-06-1 | N-methylpentan-1-amine |
| IBAN-007 | 96-33-3 | methyl acrylate |
| IBAN-008 | 744266-99-7 | methyl 3-[methyl(pentyl)amino]propanoate |
| IBAN-009 | 287395-61-3 | 3-(methyl(pentyl)amino)propanoic acid |
| Code | CAS No. | Intermediate |
|---|---|---|
| IBAN-003 | 22710-00-5 | 3-(methyl(pentyl)amino)propanoic acid hydrochloride |
| IBAN-006 | 25419-06-1 | N-methylpentan-1-amine |
| IBAN-007 | 96-33-3 | methyl acrylate |
| IBAN-008 | 744266-99-7 | methyl 3-[methyl(pentyl)amino]propanoate |
| IBAN-010 | 625120-81-2 | 3-[methyl(pentyl)amino]propanoic acid;hydrochloride |
| IBAN-011 | 105-58-8 | diethyl carbonate |
| Code | CAS No. | Intermediate |
|---|---|---|
| IBAN-005 | 77223-58-6 | N-benzyl-N-methylpentan-1-amine |
| IBAN-006 | 25419-06-1 | N-methylpentan-1-amine |
| IBAN-008 | 744266-99-7 | methyl 3-[methyl(pentyl)amino]propanoate |
| IBAN-010 | 625120-81-2 | 3-[methyl(pentyl)amino]propanoic acid;hydrochloride |
| IBAN-012 | 103-67-3 | N-methyl-1-phenylmethanamine |
| IBAN-013 | 110-53-2 | 1-bromopentane |
| IBAN-014 | 3395-91-3 | methyl 3-bromopropanoate |
| Code | CAS No. | Intermediate |
|---|---|---|
| IBAN-009 | 287395-61-3 | 3-(methyl(pentyl)amino)propanoic acid |
| IBAN-013 | 110-53-2 | 1-bromopentane |
| IBAN-015 | 693-05-0 | 3-(methylamino)propanenitrile |
| IBAN-016 | 919491-64-8 | methyl 3-(methyl(pentyl)amino)propanoate |
| IBAN-017 | 114084-78-5 | [1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl]phosphonic acid |
| Code | CAS No. | Intermediate |
|---|---|---|
| IBAN-013 | 110-53-2 | 1-bromopentane |
| IBAN-018 | 79-10-7 | acrylic acid |
| IBAN-019 | 24549-12-0 | methyl 3-(methylamino)propanoate |
| IBAN-020 | 128202-57-3 | [1-hydroxy-3-(methylamino)-1-phosphonopropyl]phosphonic acid |
Frequently asked questions
What are the approved indications of Ibandronate Sodium Hydrate?
Approved indications include: Osteoporosis, Postmenopausal osteoporosis, Hypercalcaemia, Bone injury, Breast cancer, Metastatic cancer.
When does the Ibandronate Sodium Hydrate patent expire?
No public expiry year is available for Ibandronate Sodium Hydrate yet; this page updates once verified.
How many synthesis routes are recorded for Ibandronate Sodium Hydrate?
5 synthesis routes are recorded; the shortest is 3 steps with 126.00 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Ibandronate Sodium Hydrate intermediates?
1 intermediate CAS of Ibandronate Sodium Hydrate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Ibandronate Sodium Hydrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29